Figure 5.

Example MTR maps from (A) a subject who achieved pathological complete response and (C) a subject who had residual disease at the conclusion of therapy at the first, second, and third scan sessions. Histograms of voxel distributions of MTR at the first, second, and third MRI scans for all patients who achieved pathological complete response (B) and all patients who had residual disease (bottom row) show increased heterogeneity in the patients who achieved pCR compared with histograms of those who had residual disease (D).